Literature DB >> 11076695

Toxicokinetics of inhaled propylene in mouse, rat, and human.

J G Filser1, R Schmidbauer, F Rampf, C M Baur, C Pütz, G A Csanády.   

Abstract

A physiological toxicokinetic (PT) model was developed for inhaled propylene gas (PE) in mouse, rat, and human. Metabolism was simulated to occur in the liver (90%) and in the richly perfused tissue group (10%). The partition coefficients tissue:air were determined in vitro using tissues of mice, rats, and humans. Most of the tissues have partition coefficients of around 0.5. Only adipose tissue displays a 10 times higher value. The partition coefficient blood:air in human is 0.44, about half of that in rodents. PE can accumulate in the organism only barely. For male B6C3F1 mice and male Fischer 344/N rats, parameters of PE metabolism were obtained from gas uptake experiments. Maximum rates of metabolism (V(maxmo)) were 110 micromol/h/kg in mice and 50.4 micromol/h/kg in rats. V(maxmo)/2 was reached in mice at 270 ppm and in rats at 400 ppm of atmospheric PE. Pretreatment of the animals with sodium diethyldithiocarbamate resulted in an almost complete inhibition of PE metabolism in both species. Preliminary toxicokinetic data on PE metabolism in humans were obtained in one volunteer who was exposed up to 4.5 h to constant concentrations of 5 and 25 ppm PE. The PT model was used to calculate PE blood concentrations at steady state. At 25 ppm, the blood values were comparable across species, with 0.19, 0.32, and 0.34 micromol/L for mouse, rat, and human, respectively. However, the corresponding rates of PE metabolism differed dramatically, being 8.3, 2.1, and 0.29 micromol/h/kg in mouse, rat, and human. For a repeated human exposure to 25 ppm PE in air (8 h/day, 5 days/week), PE concentrations in venous blood were simulated. The prediction demonstrates that PE is eliminated so rapidly that it cannot accumulate in the organism. For low exposure concentrations, it became obvious that the rate of uptake into blood by inhalation is limited by the blood flow through the lung and the rate of metabolism is limited by the blood flow through the metabolizing organs. Copyright 2000 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11076695     DOI: 10.1006/taap.2000.9027

Source DB:  PubMed          Journal:  Toxicol Appl Pharmacol        ISSN: 0041-008X            Impact factor:   4.219


  4 in total

1.  Effects of lead on 4-aminobiphenyl pharmacokinetics in liver, kidney, spleen, testes, heart, lung and hemoglobin adduct for rat model.

Authors:  Hui-Ming Chen; Tao Qin; Li-Xin Zhao; Xiao-Bai Xu
Journal:  Ecotoxicology       Date:  2002-08       Impact factor: 2.823

2.  Quantitative Property-Property Relationship for Screening-Level Prediction of Intrinsic Clearance of Volatile Organic Chemicals in Rats and Its Integration within PBPK Models to Predict Inhalation Pharmacokinetics in Humans.

Authors:  Thomas Peyret; Kannan Krishnan
Journal:  J Toxicol       Date:  2012-05-22

3.  Pharmacokinetic analysis of the chronic administration of the inert gases Xe and Ar using a physiological based model.

Authors:  Ira Katz; Jacqueline Murdock; Marc Palgen; Jan Pype; Georges Caillibotte
Journal:  Med Gas Res       Date:  2015-05-29

4.  Ethylene oxide in blood of ethylene-exposed B6C3F1 mice, Fischer 344 rats, and humans.

Authors:  Johannes Georg Filser; Winfried Kessler; Anna Artati; Eva Erbach; Thomas Faller; Paul Erich Kreuzer; Qiang Li; Josef Lichtmannegger; Wanwiwa Numtip; Dominik Klein; Christian Pütz; Brigitte Semder; György András Csanády
Journal:  Toxicol Sci       Date:  2013-09-25       Impact factor: 4.849

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.